Walgreens is reporting February sales of $5.31 billion, an increase of 3.2 percent from $5.14 billion for the same month in 2009. Sales in comparable stores (those open at least a year) increased 0.4 percent.
February pharmacy sales increased 3.7 percent, while comparable pharmacy sales increased 0.9 percent. Comparable pharmacy sales were negatively affected by 2.4 percentage points due to generic drug introductions in the last 12 months and a lower incidence of flu compared with February 2009. Pharmacy sales accounted for 64.5 percent of total sales for the month.
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Walgreen Co. said today it has definitively agreed to acquire Duane Reade Holdings Inc., operator of a chain of 257 New-York-area drugstores, from affiliates of Oak Hill Capital Partners. The deal price is nearly $1.08 billion, including assumption of debt.
Walgreen, which called the deal "a compelling strategic acquisition," will now have a leadership position in nation’s largest retail and drugstore market.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
Walgreens Monday said it posted record earnings and sales for the fiscal first quarter of 2010. First quarter net earnings were $489 million, or 49 cents per share, a 19.6 percent increase from $408 million from 41 cents per diluted share a year ago. First quarter 2010 results include the impact of 3 cents per diluted share in restructuring and related costs associated with the company's Rewiring for Growth initiative. First quarter sales increased 9.5 percent from the prior-year quarter to $16.4 billion. Total sales in comparable stores (those open at least a year) increased 4.9 percent in the quarter, while front-end comparable store sales increased 2.7 percent.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
Walgreens said it posted November sales of $5,360,800,000, an increase of 8.7 percent from $4,933,433,000 for the same month in 2008. Sales in comparable stores (those open at least a year) increased 3.9 percent. November pharmacy sales increased 9.7 percent, while comparable pharmacy sales increased 5.7 percent. Comparable pharmacy sales were negatively impacted by 2.4 percentage points due to generic drug introductions in the last 12 months.
Sales, however, we up less than expected.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
The board of Walgreen Co. (NYSE: WAG) (NASDAQ: WAG) announced it has authorized a new $2 billion share repurchase program. The program, which expires at the end of 2013, replaces the previous $1 billion plan announced in January 2007 which had approximately $655 million remaining. Since 2004, Walgreens has repurchased more than $1.3 billion of common stock.
Walgreen's board also declared a regularly quarterly dividend of 13.75 cents per share, a 22.2 percent increase over the year-ago dividend, and set a long-term dividend payout target of 30 to 35 percent of net earnings.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
Walgreen profit fell to $436 million, or 44 cents per share, in the fiscal fourth quarter ended Aug. 31, from $443 million, or 45 cents per share, a year earlier.
Analysts, on average, had expected a profit of 39 cents per share, according to Reuters Estimates. Walgreen is beginning to benefit from a make-over that includes sprucing up stores and cutting jobs.
Track · email · face · Twitter · digg · COMMENTS
by Rich Pike
Advertisement